Lipophilicity, biomimetic retention profile and antioxidant activity of selenium species

Microchemical Journal

Volumn 110, Issue , 2013, Pages 711-718

  Tsopelas, Fotios ^a,b   Kakoulidou, Anna Tsantili ^b   Ochsenkühn Petropoulou, Maria ^a  

^a NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antioxidant activity; Human oral absorption; Human serum albumin; Immobilized artificial membrane chromatography; Protein binding; Selenium speciation

Indexed keywords

EID: 84884155784     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.microc.2013.08.009     Document Type: Article

References (38)

1. Tinggi U. Selenium: its role as antioxidant in human health. Environ. Health Prev. Med. 2008, 13:102-108.
2. Parnes H.L., House M.G., Tangrea J.A. Prostate cancer: strategies for agent development. Curr. Opin. Oncol. 2013, 25:242-251.
3. Chen Y.C., Sandeep Prabhu K., Mastro A.M. Is selenium a potential treatment for cancer metastasis?. Nutrients 2013, 5:1149-1168.
4. Stoppe C., Spillner J., Rossaint R., Coburn M., Schalte G., Wildenhues A., Marx G., Rex S. Selenium blood concentrations in patients undergoing elective cardiac surgery and receiving perioperative sodium selenite. Nutrition 2013, 29:158-165.
5. Tanguy S., Gtauzam S., de Leiris J., Boucher F. Impact of dietary selenium intake on cardiac death: experimental approaches and human studies. Mol. Nutr. Food Res. 2012, 56:1106-1121.
6. Thiry C., Ruttens A., De Temmerman L., Schneider Y.J., Pussemier L. Current knowledge in species-related bioavailability of selenium in food. Food Chem. 2012, 130:767-784.
7. Gammelgaard B., Gabel-Jensen C., Sturup S., Hansen H.R. Complementary use of molecular and element-specific mass spectrometry for identification of selenium compounds related to human selenium metabolism. Anal. Bioanal. Chem. 2008, 390:1691-1706.
8. Solovyev N., Berthele A., Michalke B. Selenium speciation in paired serum and cerebrospinal fluid samples. Anal. Bioanal. Chem. 2013, 405:1875-1885.
9. Lu A., Rumpler A., Francesconi K.A., Pergantis S.A. Quantitative selenium speciation in human urine by liquid chromatography-electrospray tandem mass spectrometry. Anal. Chim. Acta 2012, 731:49-59.
10. Chand V., Prasad S. Trace determination and chemical speciation of selenium in environmental water samples using catalytic kinetic spectrophotometric method. J. Hazard. Mater. 2009, 165:780-788.
11. van de Waterbeemd H., Testa B. Advances in Drug Research 1987, vol. 16:85-227. Acedemic, New York. B. Testa (Ed.).
12. Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth. Pharm. Res. 1997, 14:763-766.
13. Kotecha J., Shah S., Rathod I., Subbaiah G. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors. Int. J. Pharm. 2008, 360:96-106.
14. Valko K. Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. J. Chromatogr. A 2004, 1037:299-310.
15. Gammelgaard B., Rasmussen L.H., Gabel-Jensen C., Steffansen B. Estimating intestinal absorption of inorganic and organic selenium compounds by in vitro flux and biotransformation studies in Caco-2 cells and ICP-MS detection. Biol. Trace Elem. Res. 2012, 145:248-256.
16. Pick D., Degen C., Leiterer M., Jahreis G., Einax J.W. Transport of selenium species in Caco-2 cells: analytical approach employing the Ussing chamber technique and HPLC-ICP-MS. Microchem. J. 2013, 110:8-14.
17. Ballatori N., Krance S.M., Marchan R., Hammond C.L. Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol. Aspects Med. 2009, 30:13-28.
18. Snudd Singh S., Mehta J. Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration. J. Chromatogr. B 2006, 834:108-116.
19. Vallianatou T., Lambrinidis G., Tsantili-Kakoulidou A. In silico prediction of human serum albumin binding for drug leads. Expert Opin. Drug Discov. 2013, 8:583-595.
20. Chrysanthakopoulos M., Giaginis C., Tsantili-Kakoulidou A. Retention of structurally diverse drugs in human serum albumin chromatography and its potential to simulate plasma protein binding. J. Chromatogr. A 2010, 1217:5761-5768.
21. Serifi O., Tsopelas F., Kypreou A.M., Ochsenkühn-Petropoulou M., Kefalas P., Detsi A. Antioxidant behaviour of 2'-hydroxy-chalcones: a study of their electrochemical properties. J. Phys. Org. Chem. 2013, 26:226-231.
22. Martinez S., Valek L., Resetic J., Ferenec-Ruzic D. Cyclic voltammetry study of plasma antioxidant capacity - comparison with the DPPH and TAS spectrophotometric methods. J. Electroanal. Chem. 2006, 588:68-73.
23. Tsopelas F., Ochsenkühn-Petropoulou M., Tsantili- Kakoulidou A., Ochsenkühn K.M. Study of the lipophilicity of selenium species. Anal. Bioanal. Chem. 2005, 381:420-426.
24. Tsopelas F., Tsantili-Kakoulidou A., Ochsenkühn-Petropoulou M. Investigation of the chromatographic behaviour of some selenium species - comparison with their octanol-water partitioning. Talanta 2007, 73:127-133.
25. Tsopelas F., Tsantili-Kakoulidou A., Ochsenkühn-Petropoulou M. Biomimetic chromatographic analysis of selenium species: application for the estimation of their pharmacokinetic properties. Anal. Bioanal. Chem. 2010, 397:2171-2180.
26. Tsopelas F., Tsantili-Kakoulidou A., Ochsenkühn-Petropoulou M. Exploring the elution mechanism of selenium species on liquid chromatography. J. Sep. Sci. 2011, 34:376-384.
27. Tsopelas F., Ochsenkühn-Petropoulou M., Tsantili-Kakoulidou A. Void volume markers in reversed-phase and biomimetic chromatography. J. Chromatogr. A 2010, 1217:2847-2854.
28. Lombardo F., Shalaeva M.Y., Tupper K.A., Gao F. ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. J. Med. Chem. 2001, 44:2490-2497.
29. Giaginis C., Theocharis S., Tsantili-Kakoulidou A. Contribution to the standardization of the chromatographic conditions for the lipophilicity assessment of neutral and basic drugs. Anal. Chim. Acta 2006, 573-574:311-318.
30. Hodes G. Chemical Solution Deposition of Semiconductor Films 2002, Marcel Dekker Inc., New York.
31. Vrakas D., Giaginis C., Tsantili-Kakoulidou A. Electrostatic interactions and ionization effect in immobilized artificial membrane retention: a comparative study with octanol-water partitioning. J. Chromatogr. A 2008, 1187:67-78.
32. Vrakas D., Giaginis C., Tsantili-Kakoulidou A. Different retention behavior of structurally diverse basic and neutral drugs in immobilized artificial membrane and reversed-phase high performance liquid chromatography: comparison with octanol-water partitioning. J. Chromatogr. A 2006, 1116:158-164.
33. Tsopelas F., Ochsenkühn-Petropoulou M., Zikos N., Spyropoulou E., Andreadou I., Tsantili-Kakoulidou A. Electrochemical study of some non-steroid anti-inflammatory drugs: solvent effect and anti-oxidant activity. J. Solid State Electrochem. 2011, 15:1099-1108.
34. Sharma A.K., Amin S. Post SELECT: selenium on trial. Futur. Med. Chem. 2013, 5:163-174.
35. Yan L., Demars L.C. Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice. Int. J. Cancer 2012, 131:1260-1266.
36. Ochsenkühn-Petropoulou M., Tsopelas F. Speciation analysis of selenium using voltammetric techniques. Anal. Chim. Acta 2002, 467:167-178.
37. Ochsenkühn-Petropoulou M., Tsopelas F. Separation of organoselenium compounds and their electrochemical detection. Anal. Bioanal. Chem. 2004, 379:770-776.
38. Bard A.J., Faulkner L.R. Electrochemical Methods, Fundamentals & Applications 2001, John Wiley & Sons Publications, USA. 2nd edition.